Ephedrine Hydrochloride

HCID 65326CAS 50-98-6

基本情報

標準SMILES
CN[C@@H](C)[C@H](O)c1ccccc1.Cl
InChIKey
BALXUFOVQVENIU-GNAZCLTHSA-N
分子式
C10H16ClNO
平均分子量
201.69 g/mol
単同位体質量
201.09204181

概要

Ephedrine hydrochloride is an alkylbenzene.

名称と識別子

優先名称
Ephedrine Hydrochloride
IUPAC
(1R,2S)-2-(methylamino)-1-phenylpropan-1-ol;hydrochloride

名称と別名

Ephedrine hydrochloride50-98-6(-)-Ephedrine hydrochlorideL-Ephedrine hydrochlorideEPHEDRINE HCLDTXSID1045825REZIPRESNLJ6390P1ZEphedrini hydrochloridumNSC-759611DTXCID9025825Benzenemethanol, alpha-(1-(methylamino)ethyl)-, hydrochloride, (R-(R*,S*))-
名称をさらに表示
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, hydrochloride, (alphaR)-BronchipaxTaumasthmanAsmapaxExpurhinTabasanSecronEphed hcl

データベース識別子

CAS
50-98-6
PubChem CID
65326
DTXSID
DTXSID1045825
ChEMBL
CHEMBL2146102
ChEBI
CHEBI:31541
UNII
NLJ6390P1Z
EC Number
200-074-6

物性

構造計算による物性

極性表面積
32.3 Ų
水素結合供与体数
3
水素結合受容体数
2
回転可能結合数
3
重原子数
13

実験および物理化学的性質

Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

安全と法規制

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 114 reports by companies from 7 notifications to the ECHA C&L Inventory.

危険有害性情報

Regulatory Information · 2 件

Status: Active Update: 08-11-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/10058

Ephedrine hydrochloride: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Benzenemethanol, .alpha.-[1-(methylamino)ethyl]-, hydrochloride, [R-(R*,S*)]-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

化学と産業

薬理情報

FDA Pharmacological Classification · 2 件

EPHEDRINE HYDROCHLORIDE

Increased Norepinephrine Activity [PE]; Norepinephrine Releasing Agent [EPC]; Adrenergic beta-Agonists [MoA]; Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

MeSH Pharmacological Classification · 4 件

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.

Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters.

Drugs used to cause constriction of the blood vessels.

Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.

用途と製造

General Manufacturing InformationBenzenemethanol, .alpha.-[(1S)-1-(methylamino)ethyl]-, hydrochloride (1:1), (.alpha.R)-: ACTIVE

関連反応

6 件

関連ノート

読み込み中…